APA (7th ed.) Citation

A, S., H, O., NA, B., MR, T., D, G., PB, W., . . . H, O. (2024). A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas. Neuro-oncology, 26(2), 335. https://doi.org/10.1093/neuonc/noad185

Chicago Style (17th ed.) Citation

A, Saijo, et al. "A Combinatory Vaccine with IMA950 Plus Varlilumab Promotes Effector Memory T-cell Differentiation in the Peripheral Blood of Patients with Low-grade Gliomas." Neuro-oncology 26, no. 2 (2024): 335. https://doi.org/10.1093/neuonc/noad185.

MLA (9th ed.) Citation

A, Saijo, et al. "A Combinatory Vaccine with IMA950 Plus Varlilumab Promotes Effector Memory T-cell Differentiation in the Peripheral Blood of Patients with Low-grade Gliomas." Neuro-oncology, vol. 26, no. 2, 2024, p. 335, https://doi.org/10.1093/neuonc/noad185.